Updated Jul 16, 2026 · Last SEC filing 2026-06-17
ANAPTYSBIO, INC (ANAB) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-17. 7 Form 8-K material event filings were reported by ANAB in the last 90 days. 25 Form 144 notices of proposed sale were filed for ANAB stock. InsiderAlpha tracks every ANAB SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001370053 |
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 7 |
| Form 144 notices (90d) | 25 |
| Latest Form 4 filing | 2026-06-17 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Orwin John A | Insider | M — Option exercise | 6.0K | $0.00 | — | SEC | |
| RENTON HOLLINGS | Insider | M — Option exercise | 6.0K | $0.00 | — | SEC | |
| Schmid John P. | Insider | M — Option exercise | 6.0K | $0.00 | — | SEC | |
| Schmid John P. | Insider | S — Open-market sale | 522 | $57.40 | $30K | SEC | |
| Schmid John P. | Insider | S — Open-market sale | 7.5K | $56.70 | $427K | SEC | |
| Schmid John P. | Insider | S — Open-market sale | 12.6K | $55.71 | $702K | SEC | |
| Faga Daniel | President, CEO | S — Open-market sale | 490 | $59.62 | $29K | SEC | |
| Faga Daniel | President, CEO | S — Open-market sale | 3.2K | $64.19 | $203K | SEC | |
| Faga Daniel | President, CEO | S — Open-market sale | 510 | $56.61 | $29K | SEC | |
| Faga Daniel | President, CEO | S — Open-market sale | 3.0K | $65.20 | $198K | SEC | |
| Faga Daniel | President, CEO | S — Open-market sale | 1.0K | $62.15 | $63K | SEC | |
| Faga Daniel | President, CEO | S — Open-market sale | 100 | $65.99 | $7K | SEC | |
| Faga Daniel | President, CEO | S — Open-market sale | 3.7K | $58.62 | $215K | SEC | |
| Faga Daniel | President, CEO | S — Open-market sale | 2.6K | $57.91 | $149K | SEC | |
| Faga Daniel | President, CEO | S — Open-market sale | 2.6K | $63.35 | $164K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for ANAPTYSBIO, INC (ANAB). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Schmid John P. | 22 | — |
| RENTON HOLLINGS | 22 | — |
| Faga Daniel | 15 | — |
| Orwin John A | 12 | — |
| Hughes Owen | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ANAB insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ANAB dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.